Published in Law and Health Weekly, October 3rd, 2009
The abstract presents data from a Phase 1b study of CD-NP in chronic heart failure patients. In this study, a 24-hour infusion of CD-NP resulted in improved renal function as measured by creatinine clearance (p < 0.01) compared with a 24-hour baseline period where patients received standard heart failure medications including furosemide.
"We believe that these data are very promising, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly